Adverse event profile of albumin-bound paclitaxel: a real-world pharmacovigilance analysis

• Egile Nagusiak: Yuanqiong Duan (Egilea), Ying Wang (Egilea), Shentao Lu (Egilea), Mei Zeng (Egilea), Lubin Liu (Egilea), Qian Dai (Egilea), Rutie Yin (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2024-10-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

BackgroundAbraxane plays a crucial role in the treatment of various types of cancer, despite the considerable attention it has garnered for its adverse drug events (ADEs). Nevertheless, there is currently a significant lack of comprehensive real-world pharmacovigilance studies on the ADEs associated...